One of the strange realities of life is the fact that you can live much more cheaply when you're rich than you can when you're poor. When you have money, a lot of the costs people without money face either go away entirely or become substantially cheaper and easier to manage.
Friday morning began quietly on Wall Street, with a general lack of news allowing major market benchmarks to stay close to where they began the day. Some market participants pointed to disappointing economic data on retail sales as a sign of negative consumer sentiment, but they
Investors have pushed Lowe's (NYSE: LOW) stock returns well above the broader market this year, which is no shock given that consumer spending has surged in its home improvement retailing niche. But the chain has even outpaced its bigger rival Home Depot (NYSE: HD) in 2020, main
What happened
Shares of DraftKings (NASDAQ: DKNG) are falling 5% in morning trading after the sports-wagering outfit reported second-quarter results that struck out on hitting analyst earnings expectations.
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Fifth Third Bancorp (FITB) is now the #189 analyst pick, moving up by 1 spot.
What happened
Shares of iQIYI (NASDAQ: IQ) sank on Friday after the Chinese streaming company reported its second-quarter results. The headline numbers were mixed relative to analyst expectations, and iQIYI disclosed an SEC investigation stemming from a report from short-seller
The idea of an Apple (NASDAQ: AAPL) services bundle has been around for about four years or so, but it might become a reality in just a couple months. The iPhone maker is readying a series of bundles for its various services, according to a report from Bloomberg.
What happened
Shares of Mesoblast (NASDAQ: MESO) were skyrocketing 49.5% higher as of 11:23 a.m. EDT on Friday. The huge jump came after the Australian biotech announced an FDA advisory committee vote recommending approval of Ryoncil in treating pediatric patients with steroid-r
For those looking to find strong Computer and Technology stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Veeva Systems (VEEV) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance t
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. West Pharmaceutical Services (WST) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favora
Investors focused on the Computer and Technology space have likely heard of Appian (APPN), but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Computer and Techn
Investors interested in Computer and Technology stocks should always be looking to find the best-performing companies in the group. Is Garmin (GRMN) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Computer and Technolo
Investors focused on the Basic Materials space have likely heard of Royal Gold (RGLD), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of RGLD and the rest of
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This value-quant strategy screens for high book-to-market stocks, and then separates out financially sound firms by looking at a host of improving f
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative